Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19891 | 26281317 | Turk J Med Sci | Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH). | 2015 | Details |
| A19899 | 26278387 | Curr Mol Pharmacol | Review: Precision Cut Liver Slices for the Evaluation of Fatty Liver and Fibrosis. | 2017 | Details |
| A19904 | 26273651 | Biomed Res Int | Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators. | 2015 | Details |
| A19907 | 26273604 | Biomed Res Int | The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19925 | 26262841 | J Agric Food Chem | Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. | 2015 | Details |
| A19930 | 26258810 | Eur J Cancer Prev | Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis. | 2016 | Details |
| A19932 | 26256903 | Ann Hepatol | Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. | 2016 | Details |
| A19939 | 26253086 | Clin Sci (Lond) | CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. | 2015 | Details |
| A19947 | 26250514 | Obesity (Silver Spring) | Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. | 2015 | Details |
| A19951 | 26244718 | J Investig Med | Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology. | 2015 | Details |
| A19955 | 26242257 | Curr Med Chem | Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19977 | 26229237 | Mediators Inflamm | CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19993 | 26219393 | Curr Med Chem | The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular). | 2015 | Details |
| A19995 | 26216030 | Clin Res Hepatol Gastroenterol | Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis. | 2015 | Details |
| A20008 | 26207852 | J Agric Food Chem | Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20041 | 26194065 | Cytokine | PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. | 2015 | Details |
| A20049 | 26191218 | Int J Clin Exp Pathol | Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function. | 2015 | Details |
| A20054 | 26189985 | Clin Res Hepatol Gastroenterol | Synergy between NAFLD and AFLD and potential biomarkers. | 2015 | Details |
| A20058 | 26187450 | Toxicol Sci | Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation Associated With Fatty Liver Disease in Mice. | 2015 | Details |
| A20061 | 26185598 | World J Diabetes | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome. | 2015 | Details |
| A20069 | 26178698 | Hepatology | CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis. | 2015 | Details |
| A20077 | 26172853 | Biochim Biophys Acta | Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression. | 2015 | Details |
| A20078 | 26170532 | Mediators Inflamm | LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20098 | 26156412 | J Am Coll Nutr | Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. | 2015 | Details |
| A20107 | 26151056 | Hepatobiliary Surg Nutr | Carotenoids and non-alcoholic fatty liver disease. | 2015 | Details |
| A20110 | 26148245 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy. | 2015 | Details |
| A20116 | 26146507 | Evid Based Complement Alternat Med | Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20127 | 26138749 | Expert Rev Gastroenterol Hepatol | In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? | 2015 | Details |
| A20131 | 26137185 | Oxid Med Cell Longev | Choline and Cystine Deficient Diets in Animal Models with Hepatocellular Injury: Evaluation of Oxidative Stress and Expression of RAGE, TNF-α, and IL-1β. | 2015 | Details |
| A20133 | 26134926 | Expert Opin Drug Saf | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 | Details |
| A20134 | 26134756 | Pharm Biol | Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. | 2015 | Details |
| A20137 | 26133486 | Int J Mol Med | Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model. | 2015 | Details |
| A20146 | 26124760 | Front Immunol | Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies. | 2015 | Details |
| A20157 | 26117210 | Vascul Pharmacol | Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome. | 2015 | Details |
| A20169 | 26113985 | Open Heart | Capsaicin may have important potential for promoting vascular and metabolic health. | 2015 | Details |
| A20173 | 26112094 | Exp Mol Pathol | Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH). | 2015 | Details |
| A20174 | 26111358 | J Gastroenterol Hepatol | Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A20175 | 26108973 | Eur J Clin Invest | Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD. | 2015 | Details |
| A20186 | 26098879 | PLoS One | Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. | 2015 | Details |
| A20192 | 26090514 | ScientificWorldJournal | Histologic and Metabolic Derangement in High-Fat, High-Fructose, and Combination Diet Animal Models. | 2015 | Details |
| A20205 | 26085904 | World J Hepatol | Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of genetics. | 2015 | Details |
| A20213 | 26080824 | Zhonghua Nei Ke Za Zhi | [Myosin light chain kinase involved in change of intestinal mucosal barrier function in nonalcoholic steatohepatitis mice model]. | 2015 | Details |
| A20219 | 26078579 | World J Gastroenterol | Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A20220 | 26078565 | World J Gastroenterol | Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. | 2015 | Details |
| A20222 | 26078557 | World J Gastroenterol | What are the effects of proton pump inhibitors on the small intestine? | 2015 | Details |
| A20236 | 26071652 | PM R | Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20237 | 26070860 | Expert Rev Gastroenterol Hepatol | Physiology and pathophysiology of liver lipid metabolism. | 2015 | Details |
| A20260 | 26058518 | Antioxid Redox Signal | Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20267 | 26055245 | Nat Rev Gastroenterol Hepatol | Inflammasome activation and function in liver disease. | 2015 | Details |
| A20272 | 26052375 | World J Hepatol | Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. | 2015 | Details |
| A20277 | 26049666 | Clin Investig Arterioscler | [Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis]. | 2015 | Details |
| A20286 | 26045616 | Am J Physiol Gastrointest Liver Physiol | Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. | 2015 | Details |
| A20289 | 26045268 | Dig Dis | Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development. | 2015 | Details |
| A20291 | 26043290 | Eur J Gastroenterol Hepatol | Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20297 | 26040363 | Nutr Hosp | Effect of the intake of liquids rich in polyphenols on blood pressure and fat liver deposition in rats submitted to high-fat diet. | 2015 | Details |
| A20302 | 26039731 | PLoS One | Intravenous Mycobacterium Bovis Bacillus Calmette-Guérin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice. | 2015 | Details |
| A20314 | 26033364 | Exp Cell Res | MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression. | 2015 | Details |
| A20316 | 26032587 | Pharmacol Res | Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. | 2015 | Details |
| A20322 | 26028579 | Gastroenterology | Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20326 | 26028039 | Curr Drug Targets | IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. | 2015 | Details |
| A20327 | 26027904 | Biochim Biophys Acta | Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. | 2015 | Details |
| A20335 | 26024975 | Endocrine | Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis? | 2015 | Details |
| A20336 | 26024755 | Metabolism | Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. | 2015 | Details |
| A20337 | 26024397 | Rocz Panstw Zakl Hig | Health effects of changes in the structure of dietary macronutrients intake in western societies. | 2015 | Details |
| A20340 | 26021772 | Saudi J Gastroenterol | The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease. | 2016 | Details |
| A20342 | 26020857 | Nanomedicine (Lond) | Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis. | 2015 | Details |
| A20348 | 26019451 | World J Gastroenterol | Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease. | 2015 | Details |
| A20349 | 26019445 | World J Gastroenterol | Liver involvement in pediatric celiac disease. | 2015 | Details |
| A20355 | 26018806 | Mol Med | Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis. | 2015 | Details |
| A20356 | 26018346 | Mol Med Rep | Intrahepatic transplantation of adipose-derived stem cells attenuates the progression of non-alcoholic fatty liver disease in rats. | 2015 | Details |
| A20365 | 26013469 | J Nutr Biochem | Platelet-activating factor modulates fat storage in the liver induced by a high-refined carbohydrate-containing diet. | 2015 | Details |
| A20371 | 26005678 | Hepatobiliary Surg Nutr | The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20372 | 26005677 | Hepatobiliary Surg Nutr | Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. | 2015 | Details |
| A20377 | 26003827 | J Endocrinol Invest | Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link? | 2015 | Details |
| A20379 | 26003186 | Eur J Nutr | Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. | 2015 | Details |
| A20383 | 26000287 | Biomed Res Int | Inhibitory effects of eucalyptus and banaba leaf extracts on nonalcoholic steatohepatitis induced by a high-fructose/high-glucose diet in rats. | 2015 | Details |
| A20384 | 25999863 | Front Physiol | The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels. | 2015 | Details |
| A20385 | 25999428 | Am J Physiol Gastrointest Liver Physiol | The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. | 2015 | Details |
| A20402 | 25989356 | Am J Pathol | NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. | 2015 | Details |
| A20412 | 25984739 | Nutrients | MiRNA-194 Regulates Palmitic Acid-Induced Toll-Like Receptor 4 Inflammatory Responses in THP-1 Cells. | 2015 | Details |
| A20426 | 25974206 | Sci Rep | Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice. | 2015 | Details |
| A20430 | 25972092 | Biol Pharm Bull | Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. | 2015 | Details |
| A20431 | 25971926 | Int J Obes (Lond) | Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice. | 2015 | Details |
| A20436 | 25967348 | Eur J Pharmacol | Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2015 | Details |
| A20442 | 25961500 | Sci Rep | Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20445 | 25958919 | Clin Exp Dermatol | Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. | 2015 | Details |
| A20447 | 25957914 | Int J Biochem Cell Biol | Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway. | 2015 | Details |
| A20450 | 25956613 | Hepatol Int | Comparative clinical study between the effect of fenofibrate alone and its combination with pentoxifylline on biochemical parameters and liver stiffness in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20451 | 25955209 | Cell Metab | Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. | 2015 | Details |
| A20455 | 25951129 | Nutrients | Can skin exposure to sunlight prevent liver inflammation? | 2015 | Details |
| A20460 | 25947915 | Biol Pharm Bull | The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A20467 | 25941527 | Front Immunol | The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation. | 2015 | Details |
| A20477 | 25937862 | World J Hepatol | Non-alcoholic fatty liver disease: The diagnosis and management. | 2015 | Details |
| A20483 | 25934114 | Nutr Res | Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model. | 2015 | Details |
| A20491 | 25925967 | Phytomedicine | [6]-gingerol dampens hepatic steatosis and inflammation in experimental nonalcoholic steatohepatitis. | 2015 | Details |
| A20494 | 25922835 | Biomed Res Int | Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory Cytokines. | 2015 | Details |
| A20508 | 25916635 | Biochim Biophys Acta | Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway. | 2015 | Details |